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Short-course chemotherapy for tuberculosis
of the spine
A COMPARISON BETWEEN AMBULANT TREATMENT AND
RADICAL SURGERY - TEN-YEAR REPORT
R. Parthasarathy, K. Sriram, T. Santha, R. Prabhakar,
P. R. Somasundaram, S. Sivasubramanian
From the Tuberculosis Research Centre and the Chennai Medical College, Chennai
(Madras}, South India
e performed a randomised, controlled clinicalWtrial to compare ambulant short-course
chemotherapy with anterior spinal fusion plus
short-course chemotherapy for spinal tuberculosis
without paraplegia. Patients with active disease of
vertebral bodies were randomly allocated to one of
three regimens: a) radical anterior resection with bone
grafting plus six months of daily isoniazid plus
rifampicin (Rad6); b) ambulant chemotherapy for six
months with daily isoniazid plus rifampicin (Amb6);
or c) similar to b) but with chemotherapy for nine
months (Amb9).
Ten years from the onset of treatment, 90% of 78
Rad6, 94% of 78 Amb6 and 99% of 79 Amb9 patients
had a favourable status.
Ambulant chemotherapy for a period of six months
with daily isoniazid plus rifampicin (Amb6) was an
effective treatment for spinal tuberculosis except in
patients aged less than 15 years with an initial angle
of kyphosis of more than 30° whose kyphosis
increased substantially.
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This study was conducted by the Indian Council of Medical Research in
collaboration with the British Medical Research Council. The successive
Chairmen of the British Medical Research Council (BMRC) Working
Party on Tuberculosis of the Spine have been: the late Sir H. J. Seddon and
the late Mr D. L. L. Griffiths, and the successive secretaries, the late Dr H.
Stott and Dr J. H. Darbyshire.
The patients were treated in Chennai (Madras), South India, at the
Tuberculosis Research Centre of the Indian Council of Medical Research,
and the following government hospitals in Chennai city: General Hospital,
Stanley Hospital, Royapettah Hospital, Institute for Child Health and
Hospital for Children, Kilpauk Medical College Hospital and Tuberculosis
Sanatorium, Tambaram. The orthopaedic surgeons were Professor M.
Natarajan succeeded by Professor T. K. Shanmugasundaram (Principal
Investigator), the late Professor S. T. Sundararaj, Professor S. Basheer
Ahmed, Professor S. Soundarapandian, Professor P. V. A. Mohandas, 
Professor S. Rajagopal, Professor K. Sriram and Professor P.
Soundararajan.
The study was co-ordinatcd in Chennai by the Tuberculosis Research
Centre (TRC). The members of the scientific staff of the TRC with major
responsibility for the work were: Dr S. P. Tripathy, succeeded by Dr R.
Prabhakar (Director), Dr R. Parthasarathy, Dr O. Nazareth, Dr T. Santha,
Dr R. Balasubramanian, the late Dr S. V. Rathnasabapathy, Dr V. K.
Vijayan, Dr R. Ramachandran, Dr M. S. Jawahar, Dr R. Matthew, Dr H. B.
Chandrasekar, Dr S. Krishnaswamy, Dr A. M. Rcetha, Dr P. Joseph, Dr S.
Tripathy, Dr K. C. Umapathy, Dr R. Balambal and Dr U. Ramanathan
(Medical Officers); Mrs S. Subbammal and Dr C. N. Paramasivan,
(Bacteriologists); Mr C. Alexander, (Chief Laboratory Technologist); Mr
P. R. Somasundaram, Mr S. Sivasubramanian, Mr K. G. Fredrick, M K.
Thyagarajan, Mr V. Sundaram and Dr P. Venkatesan (Statisticians); Mrs S.
Ganapathy, the late Mrs M. G. Krishnan, Mrs T. V Mathibooshanam, Miss
T. Xavier, Mrs J. S. Fredrick, Dr G. R. Shanmugam, Mrs B. E. Thomas,
Mrs M. Suhadev, Mrs N. Charles, Mrs M. Dilip and Dr S. Thilakavathy
(Medical Social Workers); and Mr K. N. Gopilingham (Chief X-ray
Technician).
In England the co-ordination was undertaken in London by Dr J. H.
Darbyshire of the BMRC Tuberculosis and Chest Diseases Unit*. Mr G.
Walker was the independent assessor of the spinal radiographs.
* Presently with MRC HIV Clinical Trials Centre, London.
Resection of the tuberculous focus and anterior spinal
fusion, the modified ‘Hong Kong’ operation, is a surgical
procedure for the treatment of tuberculosis of the spine.
This optration, in combination with long-term (18 months)
chemotherapy consisting of isoniazid plus p-aminosali-
cylic acid was investigated in Hong Kong.’ In many devel-
oping countries it may not be possible to undertake this
surgery because of limited facilities, inadequate hospital
beds and financial constraints. Under such circumstances
the best available method of treatment for spinal tuberculo-
sis appears to be chemotherapy on an ambulant basis. 2,3
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Short-course (6 or 9 months) regimens of chemotherapy,
based on daily isoniazid and rifampicin are highly effective
in smear-positive pulmonary tuberculosis.4,5 A six-month
regimen of daily isoniazid and rifampicin6,7 was expected
to be effective in spinal tuberculosis, because of its pauci-
bacillary nature.
Based on the available knowledge in the 1970s, a
randomised, concurrent, controlled clinical trial was under-
taken in Chennai (formerly known as Madras), South India,
to compare ambulant short-course (six months). chemo-
therapy with anterior spinal fusion plus six months of
chemotherapy. In case this ambulant regimen proved to be
less effective than anterior spinal fusion it, was extended to
nine months in another group to observe whether the results
would be better.
This was a collaborative investigation, the participants
being the Indian Council of Medical Research (Tuberculo-
sis Research Centre, Chennai), the British Medical
Research Council and orthopaedic surgeons attached to six
government hospitals in Chennai. The period of intake for
the study was from May 1975 to December 1978. The
three- and five-year results have already been reported. 8,9
This report describes the findings up to ten years.
Organisation and conduct of the study
Full details have been given in earlier reports8,9 and are
summarised here.
Eligibility criteria. Patients with clinically and radio-
logically active tuberculosis of the spine involving any
vertebral body from the first thoracic to the first sacral,
Table I. Details of the 235 patients available for the ten-year analysis
Patients (%)
Rad6 Amb6 A m b 9  A l l
Age in years
0 to 14 
15 to 34
35 or more
Site of lesion*
Thoracic
Thoracolumbar
Lumbar
Lumbosacral
Number of vertebrae involved*
1 or 2
3 or 4
5 or 6
Total vertebral body loss*
0.0 to 0.9
1.0 to 1.9
2.0 to 2.9
Angle of kyphosis (degrees)*†
0 to 30
31 to 60
Total
32   45 28 35
41 38 39 40
21 17 33 26
33 37 41 37
15 15 11 14
44 42 39 42
8 5 9 7
64 73 66
32 23 30
4 4 4 4
68 66 80 71
26 27 18 23
6 6 3 5
61 56 65 60
39 44 35 40
78 78 79 235
* based on independent radiological assessments
† for patients without a lordotic angle and with lesions up to L2 only (28
Rad6, 41 Amb6, 38 Amb9)
inclusive, were eligible for admission to the study. Patients
were ineligible if they had paralysis of the lower limbs
severe enough to prevent them from walking across a room,
serious extraspinal disease (tuberculous or non-tubercu-
lous), a history of previous specific chemotherapy for 12
months or more, or had already had major surgery for the
spinal disease.
Pretreatment assessments. In brief, the-assessments at the
start consisted of a detailed clinical examination, antero-
posterior and lateral radiographs of the whole spine and
posteroanterior films of the chest.
Detailed bacteriological examinations of sputum, pus,
urine and specimens removed at surgery were also con-
ducted when applicable.
Allocation to treatment. Patients were allocated, at ran-
dom, to one of the following three treatment series.
1) Rad6. Surgery plus isoniazid (5 to 7 mg/kg body-
weight) and rifampicin (10 to 15 mg/kg) together in one
dose daily for six months. The surgery consisted of radical
excision of the tuberculous focus and repair of the resultant
gap with autologous bone grafts, according to a technique
developed in Hong Kong. It was carried out within one
month of the start of chemotherapy.
2) Amb6. Ambulatory chemotherapy with isoniazid plus
rifampicin (drug dosages as in Rad6) daily in one dose for
six months.
3) Amb9. As in 2) but for nine months.
Assessments of progress. The details of assessments of
progress up to five years have been described previously.9
Between five and ten years the patients were assessed.
annually by the same methods. If a patient did not report
for follow-up, appropriate retrieval action was taken.
Results
Study population. In all, 304 (100 Rad6, 101 Amb6, 103
Amb9) patients were admitted. Of these, 54 were excluded
from the five-year analysis9 since 13 did not have active
tuberculosis, six were unfit for surgery or anaesthesia or
refused surgery, 13 had died from non-tuberculous causes, 16
had their chemotherapy changed because of toxicity or had
missed their drugs for more than six weeks, five had addi-
tional chemotherapy for extra spinal tuberculosis and one had
the operation at the wrong level. A further 15 (4 Rad6, 4
Amb6, 7 Amb9) were excluded between five and ten years:
five (2 Rad6, 2 Amb6, 1 Amb9) had died from non-tubercu-
lous causes, three (all Amb9) were retreated (1 for tuberculo-
sis meningitis, 1 for pleuropulmonary glandular tuberculosis,
1 for recurrent discharging sinus) and seven (2 Rad6, 2
Amb6, 3 Amb9) were lost to follow-up, but had quiescent
spinal disease at the last assessment. Of the total of 69
patients excluded (23%), 22 (22%) had been allocated to
Rad6, 23 (23%) to Amb6 and 24 (23%) to Amb9. There
remained 235 (78 Rad6, 78 Amb6, 79 Amb9) patients for ten-
year analyses.
Follow-up. During the ten-year period follow-up was con-
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Rad 6 : 71 patients
Years
Amb 6 : 75 patients Amb 9 : 78 patients
Years Years
Fig. 1
The percentage of patients with complete bony fusion in the three treatment groups up to ten years
sistently
10
very high and similar (95% to 100%) in the three
series.
Characteristics on admission. The distributions of the
patients were broadly similar in the three series (Table I).
Of the 235 patients 35% were aged less than 15 years. The
site of the lesion was thoracic or thoracolumbar in 51%.
The number of vertebrae involved was three to six in 33%,
and the total loss of vertebral body was one or more in
28%. The angle of kyphosis11 was more than 30° but 60° or
less in 40% of the patients.
Deaths associated with spinal tuberculosis. Four (all
Rad6) patients died, all within the first six months. Three
were in the postoperative period and the other had compli-
cations of postoperative paraplegia.8
Modification of treatment. A total of 11 (5 Rad6, 5 Amb6,
1 Amb9) patients had modification of treatment, all within
the first three years.8 Of the five Rad6 patients, surgery was
abandoned in two for technical reasons, two required addi-
tional surgery, for posterior displacement of the bone graft
in one and for a persistent postoperative sinus in the other,
and one who died with paraplegia was given additional
chemotherapy. Of the six ambulant patients, additional
chemotherapy was given to two (both Amb6) for clinically
evident abscesses, and further surgery carried out in four (3
Amb6, 1 Amb9), including two (both Amb6) with addi-
tional chemotherapy also, because of neurological deficit.
Sinuses and/or clinically evident abscesses. The pre-
valence, incidence and resolution of sinuses and/or clini-
cally evident abscesses have been reported elsewhere.12
Patients in the Rad6 series had a faster resolution
(p < 0.001 at two months) and a lower incidence (p = 0.03)
than those in the ambulant series. There was no recurrence
of the lesions during the ten-year period.
Involvement of the central nervous system. Myelopathy
was present on admission or developed within the first two
months in 17 of 235 patients (7%). Of these, 16 recovered
(four with additional chemotherapy and/or surgery) and all
were alive and normal at ten years. The other patient 
developed postoperative paraplegia and died in the fifth 
month.
Myelopathy developed after the first two months in two 
patients, but resolved without additional chemotherapy or 
surgery. Both were alive and normal at ten years.
Bony fusion. Complete bony fusion occurred in similar 
proportions of patients in the three series up to six years, 
about 50% by two years, rising to about 80% by six years 
(Fig. 1). There was very little change after six years. At ten 
years, the rates were 90% for 71 Rad6, 81% for 75 Amb6 
and 85% for 78 Amb9 patients. The difference between the 
radical and the ambulant series combined was not sig- 
nificant (p > 0.1).
Partial bony fusion occurred in five (7%) Rad6 and 21
(14%) ambulant (11 Amb6, 10 Amb9) patients. The five 
Rad6 patients had no functional disability. Among the 21
ambulant patients, five children under ten years of age had  
considerable worsening of the kyphosis to 40° or more 
during the adolescent growth spurt.
At ten years there was no bony fusion in 3% of patients  
(2 Rad6, 3 Amb6, 2 Amb9). In the two Rad6 patients this
was due to failure of the bone graft. The five ambulant
patients had partial involvement of the vertebral bodies
without total destruction of intervertebral disc spaces; they 
had excellent functional results without increase in the
deformity.
Spontaneous fusion of the posterior elements of the spine
was found in eight patients (1 Rad6, 7 Amb6 + Amb9); all
were asymptomatic.
Angle of kyphosis. There were 107 (28 Rad6, 41 Amb6, 38
Amb9) patients with thoracic or thoracolumbar lesions. The  
mean angles of kyphosis on admission (Fig. 2) were broad-
ly similar at 26° to 30°. The mean angles at ten years were
also similar, ranging from 41° to 47°. There was an
increase in the mean angle of kyphosis in these patients
over the ten years (Fig. 3). None of the differences between  
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Rad 6 : 28 patients Amb 6 : 41 patients Amb 9 : 38 patients
Years Years
Fig. 2
Years
Mean angle of kyphosis for patients with thoracic or thoracolumbar lesions on admission and
at ten years.
Rad 6 : 28 patients Amb 6 : 41 patients Amb 9 : 38 patients
Years Years
Fig. 3
Years
Mean increases in angle of kyphosis for patients with thoracic or thoracolumbar lesions during ten years.
Age and kyphosis
angle on admission
Numbers within the
 circle indicate the number
of patients assessed
80 60 40 20 0
Mean kyphosis angle
at 10 years (degrees)
Fig. 4
6 20 40 60 80
Mean increase during
10 years (degrees)
The mean angle of kyphosis at ten years and the mean increase over ten years related to the age and
angle on admission for patients in the Rad6 group.
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Age and kyphosis
angle on admission
Fig. 5
Mean angle of kyphosis at ten years and mean
increase over ten years related to the age and angle
on admission for patients in the Amb6 and Amb9
Numbers within the
groups.
 circle indicate the number
of patients assessed
I
80 60 40 20 0 0 20 40 60 80
Mean kyphosis angle Mean increase during
at 10 years (degrees) 10 years (degrees)
Fig. 6
Scatterplot of the observed angle of kyphosis at ten years and the initial
vertebral body loss in the 79 Amb6/Amb9 patients.
the groups was significant (p > 0.1 for all the comparisons).
Most of the increase occurred within the first 18 months.
The increase in the angle was similar in those with thoracic
and thoracolumbar lesions in the radical and ambulant
series.
Analyses were undertaken to see if changes in the angle
of kyphosis during the ten years were related to the initial
angle of kyphosis and to age. It was not possible to assess
the influence of age in the Rad6 patients (Fig. 4) because of
the small numbers. Seven patients aged 15 years or more
and having an initial angle of more than 30° showed a
mean increase of 27°. In all, there was failure of the bone
graft which spanned three or more disc spaces.
In the two ambulant series, patients with an initial angle
of 30° or less, irrespective of age, had similar changes in
the angle of kyphosis. In patients with an initial angle of 
more than 30°, however, the change in the angle of kypho-
sis was related to age. In patients aged less than 15 years,
the mean increase by ten years (Fig. 5) was 30°, compared
with 10° in those aged 15 years or more (Student’s t- test,
p = 0.001); the mean angles at ten years (Fig. 5) were 73°
and 52°, respectively. Furthermore, an increase of more
than 30° (not shown in the figure) was observed in seven
and none, respectively (Fisher’s exact text, p = 0.01).
In all, 13 patients (3 Rad6, 10 Amb6 + Amb9) had an
increase of more than 30° during the ten-year period.
Influence of initial vertebral body loss on the angle of
kyphosis at ten years. A regression line was fitted for
predicting the angle of kyphosis at ten years (Y) from the
initial vertebral body loss (X) in ambulatory patients. The
equation derived was of the form Y = 22.1 + 25.0 X. The
correlation coefficient, however, was only 0.50. Also, the
predicted angle was within ±10° of the observed angle in
only 34 (43%) of 79 ambulatory patients (Fig. 6).
Results at ten years. At ten years, 90% of 78 Rad6, 94%
of 78 Amb6 and 99% of 79 Amb9 patients had a favourable
status (Table II), with no sinus or clinically evident abscess,
Table II. Status at ten years for the 235 patients available for follow-up
Status
Favourable*
Unfavourable†
Total assessed
Surgery
Rad6
Number
70
8
78
(%)
90
10
100
Ambulatory chemotherapy
Amb6 Amb9
Number (%) Number
73 94 78
5 6 1
78 100 79
(%)
99
1
100
Amb6 + Amb9
Number (%)
151 96
6 4
157 100
* as defined in text
† defined as death due to or associated with spinal tuberculosis, additional surgery and/or chemotherapy, or radical
operation abandoned for technical reasons
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no myelopathy and no modification of the allocated regi-
men. Further, they had no limitation of their physical
activity due to the spinal lesion and their disease was
radiologically quiescent. The difference between the Rad6
and Amb9 series was significant (p = 0.03). The differences
between the Rad6 and Amb6 series and that between the
Amb6 and Amb9 were not significant (p = 0.2).
In all, 14 (8 Rad6, 5 Amb6, 1 Amb9) of 235 patients had
an unfavourable status at ten years. All have been described
in detail earlier.
Progress of patients excluded from the main analyses. In
all, 69 (22 Rad6, 23 Amb6, 24 Amb9) patients were
excluded from the ten-year analyses. Of these, 56 (19 Rad6,
16 Amb6, 21 Amb9) had active spinal disease. A total of 28
patients (8 Rad6, 10 Amb6, 10 Amb9) could not be
assessed at ten years. Of these, 18 had died from non-
tuberculous causes, but had quiescent spinal disease at their
last assessment; two refused surgery at the start and eight
defaulted from follow-up. Of the remaining 28 (11 Rad6, 6
Amb6, 11 Amb9) patients, 16 (7 Rad6, 4 Amb6, 5 Amb9)
had a favourable result at ten years.
Discussion
The British Medical Research Council investigated anterior
spinal fusion in Hong Kong13 and ambulant short-course
chemotherapy in Korea14 in the treatment of tuberculosis of
the spine involving the bodies of thoracic and lumbar
vertebrae without paraplegia. A concurrent comparison of
ambulant short-course chemotherapy (Amb6, Amb9) with
anterior spinal fusion, in addition to short-course chemo-
therapy (Rad6), was conducted at the Tuberculosis
Research Centre, Chennai (Madras).8
At ten years, 94% of the Amb6 and 99% of the Amb9
series had a favourable status, the difference not being
significant (p = 0.2). The Rad6 regimen was less effective
than Amb9 (p = 0.03), 90% of patients having a favourable
status. This difference was due to surgical complications.
The outcome of the two ambulant regimens was con-
firmed by a Korean study.14 Using the same criteria, an
unfavourable response at three years was observed in 2% of
65 patients given daily isoniazid and rifampicin for six
months and in 4% of 71 given the same drugs for nine
months. Treatment with two drugs may no longer be
acceptable because of the current high levels of initial drug
resistance,15-17 the emergence of multi-drug-resistant tuber-
culosis and co-infection with HIV.18,19 Under the Revised
National Tuberculosis Control Programme in India, the
regimen recommended for severe forms of tuberculosis is
isoniazid, rifampicin, pyrazinamide and ethambutol, admin-
istered three times a week for two months, followed by
isoniazid and rifampicin given three times a week for four
months.20
Anterior spinal fusion was also investigated in Hong
Kong in combination with 18 months of isoniazid plus p- 
aminosalicylic acid1 or with six or nine months of isoniazid
plus rifampicin.13 The overall results were satisfactory, a
favourable status occurring in 86% by ten years21 and 96%
by three years,13 respectively. Anterior fusion is expected to
confer two particular benefits, namely, rapid bon
1
fusion
and arrest of progression of the gibbus deformity. Unlike
in Hong Kong, bony fusion in the surgically treated patients
was not rapid in Chennai even although the pretreatment
characteristics of the patients in the first study in Hong
Kong were similar. Fusion occurred by one year in 34% in
the Chennai study, 69% in the first Hong Kong study21 and
56% in the second Hong Kong study.13
The angle of kyphosis increased in all three treatment
groups in the present study, the mean increase being 15° for
the Rad6, compared with 17° for the Amb6 and 13° for the
Amb9 series (p > 0.1 for all three comparisons). Thus,
surgery did not arrest the progression of the gibbus deform-
ity and neither was correction achieved in the two Hong
Kong studies. In the first study the mean angle at ten years
was virtually the same as that on admission and in the
second study it had increased by 11° at three years. 13
Moon22 concluded that “it was unwise to rely solely on the
anterior strut graft to prevent vertebral collapse”. Posterior
instrumentation followed by anterior fusion was successful
in correcting the gibbus and maintaining it for a mean
period of 3.6 years.23
Considering the Rad6 patients, problems relating to the
bone graft were responsible for failure of fusion in two of
71 patients and a substantial (27°) increase in the angle of
kyphosis by ten years in seven patients aged 15 years or
more who had an initial angle of more than 30°. Upadhyay
et a124 reported dislodgement of the graft after anterior
fusion in ten (10%) of 104 patients, and an increase in the
angle by 20° or more by one year in all. Bailey et a125
followed up 100 consecutive children with spinal tubercu-
losis who were operated on and reported graft complica-
tions in 35%, including fracture in 12%. Rajasekaran and
Soundarapandian26 found that the graft failed most often in
patients in whom it spanned three or more disc spaces.
When the anterior strut graft is long, the spine is mechani-
cally unstable and the graft fails because of fracture, dis-
placement or absorption. To achieve mechanical stability of
the spine and help in the early incorporation of the graft,
the anterior fusion must be supplemented by posterior
fusion,25’27 preferably with instrumentation.23 Present tech-
niques such as CT and MRI can define the number of
diseased vertebrae and the involvement of posterior ele-
ments, and thus help in the planning of surgery.28
The management of the patients would be improved if
the final angle of kyphosis could be predicted at the start of
treatment. Rajasekaran and Shanmugasundaram29 derived
an equation for doing this, based on the initial vertebral
loss. An analysis of the angle of kyphosis at ten years in the
ambulant patients in our study. showed that the agreement
(±10°) between the angle predicted and the observed angle
was only 34% using their equation, and 43% with a revised
equation derived by us. We conclude that the angle of
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kyphosis at ten years cannot be accurately predicted based
on the initial vertebral loss in most patients. All patients
undergoing ambulant chemotherapy should be monitored
for progression of the deformity during the active phase of
the disease.
Our study gives valuable information on the influence of
age and the initial angle of kyphosis on the changes in the
gibbus deformity among the ambulant patients. Those aged
less than 15 years who had an initial angle of more than 30°
had the highest mean angle (73°) at ten years, due to an
increase of 30°. Therefore surgery is indicated in addition
to chemotherapy in these patients.
A gibbus deformity, if severe, can give rise to cardio-
respiratory failure3 and late-onset paraplegia. 30,31 Neither of
these occurred in our study. A longer period of follow-up is
needed to monitor the patients for such complications.
Leong30 pointed out that a severe worsening of kyphosis
with an increase of more than 30° occurred in about 20% of
conservatively treated patients in Korea, yet this had not been
taken into account in assessing the response to treatment.32 In
our study. there were 13 (3 Rad6, 6 Amb6, 4 Amb9) such
patients among 107. If these are reclassified as having had an
unfavourable response, the revised figures for favourable
status at ten years become 86% for Rad6, 86% for Amb6 and
94% for Amb9, the differences between the three series not
being significant (p > 0.2 for all comparisons).
4) Radical excision with anterior spinal fusion with a
stable strut graft is the operation of choice. If the graft is
expected to span three or more disc spaces, or the posterior
elements are diseased, the procedure should be supple-
mented by posterior fusion, preferably with instrumenta-
tion. Preoperative evaluation with CT and MRI when
possible, is of value in the planning of the surgery.
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